SE319577B - - Google Patents

Info

Publication number
SE319577B
SE319577B SE303166A SE303166A SE319577B SE 319577 B SE319577 B SE 319577B SE 303166 A SE303166 A SE 303166A SE 303166 A SE303166 A SE 303166A SE 319577 B SE319577 B SE 319577B
Authority
SE
Sweden
Prior art keywords
chlormethiazole
march
stabilized
composition
mixture
Prior art date
Application number
SE303166A
Other languages
English (en)
Inventor
T Rydh
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE303166A priority Critical patent/SE319577B/xx
Priority to DE1967A0054844 priority patent/DE1617286B1/de
Priority to NL6702002A priority patent/NL156921B/xx
Priority to BE693977D priority patent/BE693977A/xx
Priority to AT151867A priority patent/AT266126B/de
Priority to GB976267A priority patent/GB1147731A/en
Publication of SE319577B publication Critical patent/SE319577B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE303166A 1966-03-08 1966-03-08 SE319577B (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE303166A SE319577B (fr) 1966-03-08 1966-03-08
DE1967A0054844 DE1617286B1 (de) 1966-03-08 1967-02-09 Arzneimittel auf der Basis von 4-Methyl-5-(2'-chloräthyl)-thiazol
NL6702002A NL156921B (nl) 1966-03-08 1967-02-09 Werkwijze ter bereiding van een therapeutisch preparaat, dat als werkzaam bestanddeel 4-methyl-5-(2'-chloorethyl)-thiazool bevat, alsmede de onder toepassing van deze werkwijze bereide, gevormde therapeutische preparaten.
BE693977D BE693977A (fr) 1966-03-08 1967-02-13
AT151867A AT266126B (de) 1966-03-08 1967-02-16 Verfahren zur Stabilisierung von 4-Methyl-5-(2'-chloräthyl)-thiazol
GB976267A GB1147731A (en) 1966-03-08 1967-03-01 Improvements relating to the stabilization of chlormethiazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE303166A SE319577B (fr) 1966-03-08 1966-03-08

Publications (1)

Publication Number Publication Date
SE319577B true SE319577B (fr) 1970-01-19

Family

ID=20261249

Family Applications (1)

Application Number Title Priority Date Filing Date
SE303166A SE319577B (fr) 1966-03-08 1966-03-08

Country Status (6)

Country Link
AT (1) AT266126B (fr)
BE (1) BE693977A (fr)
DE (1) DE1617286B1 (fr)
GB (1) GB1147731A (fr)
NL (1) NL156921B (fr)
SE (1) SE319577B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren

Also Published As

Publication number Publication date
BE693977A (fr) 1967-08-14
AT266126B (de) 1968-11-11
DE1617286B1 (de) 1971-05-27
NL156921B (nl) 1978-06-15
GB1147731A (en) 1969-04-02
NL6702002A (fr) 1967-09-11

Similar Documents

Publication Publication Date Title
ES8500739A1 (es) Metodo de producir composiciones farmaceuticas de liberacion controlada y accion prolongada
PT71724A (en) Process for the preparation of new optically active 1,4-dihidropyridine derivatives having anti-hypertensive and vassodi lator effect and of pharmaceutical compositions containing thern
PT81039A (en) Process for preparing pellet formulations
IL60326A0 (en) Pharmaceutical compositions for parenteral administration of fatsolbule active substances
GB1272640A (en) Delayed or sustained release medicament dosages and a process for their manufacture
IL61207A0 (en) Cytostatically active pharmaceutical compositions comprising isocyanuric acid derivatives, certain such novel derivatives and their preparation
JPS5228922A (en) Medicine mixture for animals
DE3665668D1 (en) Pharmaceutical granulate containing ambroxol or bromohexine
SE319577B (fr)
JPS57109721A (en) Carcinostatic agent
JPS52108028A (en) Remedies for dysacousis
ES8102096A1 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
IL45136A0 (en) Process for the preparation of 3-(0,0-diethyldithiophosphorylmethyl)-6-chloro-benzoxazolone and insecticidal and acaricidal compositions containing same
GB1442159A (en) Pharmaceutical compositions containing paracetamol
ES485992A1 (es) Procedimiento para la obtencion de un fungicida a base de carboximidas y derivados sulfamidicos
JPS54151925A (en) Nn*1**methoxycarbonylethyl**nn*n**n** disubstituted hydrazinoacetyl**aniline derivative*its manufacture and fungicidal composition containing it as active component
JPS525769A (en) Preparation of 3-substituted pyrolidine derivatives
GB1294538A (en) Pharmaceutical compositions
JPS51136886A (en) New biologica lly active substance, ml-236c, and its preparation
GB992222A (en) Hypoglycemic compositions containing acyl disulphides and their esters
JPS5668611A (en) Novel antiallergic agent
GB1446237A (en) Pharmaceutical preparations containing pyrazolones
JPS5640607A (en) Drug composition
JPS5498339A (en) Carcinostatic agent
ES347271A1 (es) Procedimiento para preparar benzodiazapinas.